Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cytokinetics
Biotech
Edgewise unveils promising early data for heart disease drug
Edgewise tested its drug, dubbed EDG-7500, separately in healthy subjects and in patients with obstructive HCM.
Zoey Becker
Sep 20, 2024 4:00am
Investors say 'no bueno' to Cytokinetics' complex Royalty deal
May 23, 2024 10:36am
Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos
May 13, 2024 9:36am
Cytokinetics not in sale process, CEO says
Feb 28, 2024 11:25am
Novartis backs out of Cytokinetics deal: reports
Jan 12, 2024 5:26am
Novartis 'pretty aggressive' in neuroscience BD, R&D chief says
Jan 8, 2024 3:49pm
